Improved systolic function of rat cardiocytes during heart failure by overexpression of SERCA2a

被引:0
作者
Gong, H. -B. [1 ]
Wang, L. [1 ]
Lv, Q. [1 ]
Wang, J. [1 ]
机构
[1] Xuzhou Cent Hosp, Dept Cardiol, Xuzhou Cardiovasc Dis Inst, Xuzhou, Jiangsu, Peoples R China
关键词
SERCA2a; Overexpression; Heart failure; Arrhythmia; Cardiocyte function; GENE; MYOCYTES; LEAK;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: This study shows that overexpression of SERCA2a can improve the systolic function and reduce the occurrence of arrhythmias in cardiocytes isolated from the heart of a rat model of heart failure. MATERIALS AND METHODS: An animal model of rats experiencing heart failure was established by a surgical procedure producing abdominal aortic coarctation. Cardiocytes from sacrificed rats were isolated by a collagenase digestion method. The SERCA2a adenovirus vector was transfected into the cells after 48h of culture. Overexpression of SERCA2a in cardiocytes was verified by Western Blot. Measurements were taken using a single cell dynamic edge detection system to evaluate the effects on the myocardiocyte function and calcium homeostasis. RESULTS: Cardiocytes overexpressing SERCA2a displayed a stronger systolic function and lower occurrence rate of abnormal systolic rhythm than mock-transfected cardiocytes. The contraction rhythm abnormality rate percentage was 5.270 +/- 1.566% vs. 3.955 +/- 1.684% (p < 0.01). The time at which they reached the maximum contraction (TTP) was 0.095 +/- 0.009s vs. 0.114 +/- 0.008s (p < 0.01). The time at which they reached 50% of the diastolic amplitude (R50) was 0.039 +/- 0.008s vs. 0.057 +/- 0.010s (p < 0.01). Finally, the occurrence rate of abnormal systolic rhythm during maximal contraction was 58% vs. 81% (p < 0.01). These results show that all data were significantly improved in the SERCA2a overexpressing group, and that parameters achieved were similar to those in the sham-operated nonheart failure group. CONCLUSIONS: The overexpression of SERCA2a in cardiocytes during heart failure significantly improves cell function and arrhythmia occurrence.
引用
收藏
页码:1590 / 1596
页数:7
相关论文
共 50 条
[31]   Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy [J].
Zhu, Zhenduo ;
Guan, Qiuyun ;
Xu, Bing ;
Bahriz, Sherif ;
Shen, Ao ;
West, Toni M. ;
Zhang, Yu ;
Deng, Bingqing ;
Wei, Wei ;
Han, Yongsheng ;
Wang, Qingtong ;
Xiang, Yang K. .
BRITISH JOURNAL OF PHARMACOLOGY, 2025, 182 (07) :1487-1507
[32]   SUMO1 Modification Regulates SR Calcium ATPase Pump, SERCA2a in Heart Failure [J].
Kho, Changwon ;
Lee, Ahyoung ;
Jeong, Dongtak ;
Oh, Jae Gyun ;
Chaanine, Antoine ;
Park, Woo Jin ;
Hajjar, Roger .
CIRCULATION RESEARCH, 2012, 111 (04)
[33]   SERCA2a overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes [J].
Davia, K ;
Bernobich, E ;
Ranu, HK ;
del Monte, F ;
Terracciano, CMN ;
MacLeod, KT ;
Adamson, DL ;
Chaudhri, B ;
Hajjar, RJ ;
Harding, SE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2001, 33 (05) :1005-1015
[34]   Inhibition of p38a Regulates SERCA2a Function [J].
Kaikkonen, Leena ;
Magga, Johanna ;
Ronkainen, Veli-Pekka ;
Koivisto, Elina ;
Perjes, Abel ;
Chuprun, Kurt ;
Vinge, Leif E. ;
Aro, Jani ;
Ulvila, Johanna ;
Alakoski, Tarja ;
Bibb, James ;
Szokodi, Istvan ;
Koch, Walter J. ;
Ruskoaho, Heikki ;
Kerkela, Risto .
CIRCULATION RESEARCH, 2013, 113 (04)
[35]   Progesterone modulates SERCA2a expression and function in rabbit cardiomyocytes [J].
Moshal, Karni S. ;
Zhang, Zhe ;
Roder, Karim ;
Kim, Tae Yun ;
Cooper, Leroy ;
Litvinov, Bogdan Patedakis ;
Lu, Yichun ;
Reddy, Vishal ;
Terentyev, Dmitry ;
Choi, Bum-Rak ;
Koren, Gideon .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2014, 307 (11) :C1050-C1057
[36]   Rolipram, a PDE4 Inhibitor, Enhances the Inotropic Effect of Rat Heart by Activating SERCA2a [J].
Huang, Huili ;
Xie, Ming ;
Gao, Li ;
Zhang, Wenhui ;
Zhu, Xiaojia ;
Wang, Yuwei ;
Li, Wei ;
Wang, Rongrong ;
Chen, Kesu ;
Boutjdir, Mohamed ;
Chen, Long .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[37]   Phospholamban phosphorylation and SERCA 2a function in human heart failure [J].
Münch, G ;
Bölck, B ;
Brixius, K ;
Bloch, W ;
Schwinger, RHG .
HERZ KREISLAUF, 1999, 31 (02) :73-78
[38]   In vivo effects of nitrosyl hydrogen on cardiac function and sarcoplasmic reticulum calcium pump (SERCA2a) in rats with heart failure after myocardial infarction [J].
Guo, Yanqing ;
Xu, Jiyao ;
Deng, Yongzhi ;
Wu, Li ;
Wang, Jingping ;
An, Jian .
CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2020, 10 (06) :1795-1804
[39]   Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure [J].
Hajjar, Roger J. ;
Zsebo, Krisztina ;
Deckelbaum, Lawrence ;
Thompson, Craig ;
Rudy, Jeff ;
Yaroshinsky, Alex ;
Ly, Hung ;
Kawase, Yoshiaki ;
Wagner, Kim ;
Borow, Kenneth ;
Jaski, Brian ;
London, Barry ;
Greenberg, Barry ;
Pauly, Daniel F. ;
Patten, Richard ;
Starling, Randall ;
Mancini, Donna ;
Jessup, Mariell .
JOURNAL OF CARDIAC FAILURE, 2008, 14 (05) :355-367
[40]   Hemodynamic Response to Exercise in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients After Upregulation of SERCA2a [J].
Sarma, Satyam ;
Hieda, Michinari ;
Howden, Erin J. ;
Hearon, Christopher ;
Lawley, Justin ;
Livingston, Sheryl ;
Samels, Mitchel ;
Everding, Braden ;
Levine, Benjamin D. .
CIRCULATION, 2017, 136